Comprehensive Resources For Your Practice

Tools to better understand Zimed® PF

Patient Education Resources

Guide your patients for a better experience through disease state education and essential Zimed® PF information  

Contact us today to request print copies for your patients.

Introducing Zimed® PF to Healthcare Professionals

This presentation offers Zimed® PF efficacy and safety profile information backed by evidence from clinical trials. Discover this new drug's innovative features and benefits to the Canadian market.

Staff Training for Patient Support

“Glaucoma and Interprofessional Collaboration”
webinar arranged by OAO

Uncover the OAO webinar that discusses the impact of COVID-19 on glaucoma care in Canada, options of alternative models of access to care in an evolving healthcare system, and new therapeutical options for patients with glaucoma and ocular surface disease.

Article Thumbnail

Exclusive Access: This webinar is reserved for OAO members only. You must enter your OAO member profile credentials to watch the webinar.

WARNINGS AND PRECAUTIONS

Indication ZIMED® PF (bimatoprost ophthalmic solution 0.03% w/v) is indicated for: the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

Contraindication ZIMED® PF is contraindicated in patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container.

Most Serious Warnings and precautions Ocular inflammation: use with caution.
Macular edema: use with caution in patients with macular edema risk factors.

Other relevant warnings and precautions Increased Pigmentation: of iris, periorbital tissue or eyelashes.
Silver: avoid if history of contact sensitivity to silver.
Pregnant women: should be administered during pregnancy only if the potential benefit justifies the potential risk to the fetus.

For more information: Consult the Product Monograph for important information relating to adverse reactions, drug interactions, and dosing information which have not been discussed in this piece.
The Product Monograph is also available by calling 1-833-542-2633.

Copyrights @2023 Aequus Pharmaceuticals In. All rights reserved. Last updated August 2023